SLC6A3 and Parkinson disease: Imaging of DAT binding is useful in early diagnosis for PD and differentiation from other non-degenerative parkinsonian disorders, but it does not differentiate PD from other degenerative parkinsonisms characterized by dopaminergic cell loss.